CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

J Bousquet; G L Onorato; C Bachert; M Barbolini; A Bedbrook; L Bjermer; J Correia de Sousa; N H Chavannes; A A Cruz; E De Manuel Keenoy; P Devillier; J Fonseca; S Hun; T Kostka; P W Hellings; M Illario; J C Ivancevich; D Larenas-Linnemann; J Millot-Keurinck; D Ryan; B Samolinski; A Sheikh; A Yorgancioglu; I Agache; S Arnavielhe; M Bewick; I Annesi-Maesano; J M Anto; K C Bergmann; C Bindslev-Jensen; S Bosnic-Anticevich; J Bouchard; D P Caimmi; P Camargos; G W Canonica; V Cardona; A M Carriazo; C Cingi; E Colgan; A Custovic; R Dahl; P Demoly; G De Vries; W J Fokkens; J F Fontaine; B Gemicioğlu; N Guldemond; Z Gutter; T Haahtela; B Hellqvist-Dahl; E Jares; G Joos; J Just; N Khaltaev; T Keil; L Klimek; M L Kowalski; I Kull; P Kuna; V Kvedariene; D Laune; R Louis; A Magnan; J Malva; E Mathieu-Dupas; E Melén; E Menditto; M Morais-Almeida; R Mösges; J Mullol; R Murray; H Neffen; R O'Hehir; S Palkonen; N G Papadopoulos; G Passalacqua; J L Pépin; F Portejoie; D Price; B Pugin; F Raciborski; F E R Simons; M Sova; O Spranger; C Stellato; A Todo Bom; P V Tomazic; M Triggiani; A Valero; E Valovirta; O VandenPlas; A Valiulis; M van Eerd; M T Ventura; M Wickman; I Young; T Zuberbier; A Zurkuhlen; A Senn

doi:10.1186/s13601-017-0173-8

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

Clin Transl Allergy. 2017 Oct 23:7:37. doi: 10.1186/s13601-017-0173-8. eCollection 2017.

Authors

J Bousquet^{1

2

3}, G L Onorato¹, C Bachert⁴, M Barbolini⁵, A Bedbrook¹, L Bjermer⁶, J Correia de Sousa⁷, N H Chavannes⁸, A A Cruz^{9

10}, E De Manuel Keenoy¹¹, P Devillier¹², J Fonseca^{13

14}, S Hun¹⁵, T Kostka¹⁶, P W Hellings¹⁷, M Illario¹⁸, J C Ivancevich¹⁹, D Larenas-Linnemann²⁰, J Millot-Keurinck²¹, D Ryan²², B Samolinski²³, A Sheikh²⁴, A Yorgancioglu^{25

26}, I Agache²⁷, S Arnavielhe²⁸, M Bewick²⁹, I Annesi-Maesano³⁰, J M Anto^{31

32

33

34}, K C Bergmann^{35

36}, C Bindslev-Jensen³⁷, S Bosnic-Anticevich^{38

39}, J Bouchard^{40

41}, D P Caimmi^{42

43}, P Camargos⁴⁴, G W Canonica⁴², V Cardona⁴⁵, A M Carriazo⁴⁶, C Cingi⁴⁷, E Colgan⁴⁸, A Custovic⁴⁹, R Dahl^{9

10}, P Demoly⁴³, G De Vries⁵⁰, W J Fokkens⁵¹, J F Fontaine⁵², B Gemicioğlu⁵³, N Guldemond⁵⁴, Z Gutter⁵⁵, T Haahtela⁵⁶, B Hellqvist-Dahl⁵⁷, E Jares⁵⁸, G Joos⁵⁹, J Just^{60

61}, N Khaltaev⁶², T Keil^{63

64}, L Klimek⁶⁵, M L Kowalski⁶⁶, I Kull⁶⁷, P Kuna⁶⁸, V Kvedariene⁶⁹, D Laune²⁸, R Louis⁷⁰, A Magnan⁷¹, J Malva^{72

73}, E Mathieu-Dupas²⁸, E Melén⁷⁴, E Menditto⁷⁵, M Morais-Almeida⁷⁶, R Mösges⁷⁷, J Mullol⁷⁸, R Murray⁷⁹, H Neffen⁸⁰, R O'Hehir^{81

82}, S Palkonen⁸³, N G Papadopoulos^{84

85}, G Passalacqua⁸⁶, J L Pépin⁸⁷, F Portejoie¹, D Price^{88

89

90}, B Pugin¹⁷, F Raciborski²³, F E R Simons⁹¹, M Sova⁹², O Spranger⁹³, C Stellato⁹⁴, A Todo Bom⁹⁵, P V Tomazic⁹⁶, M Triggiani⁹⁴, A Valero⁹⁷, E Valovirta⁹⁷, O VandenPlas⁹⁸, A Valiulis⁹⁸, M van Eerd⁵⁰, M T Ventura⁹⁹, M Wickman⁷⁴, I Young¹⁰⁰, T Zuberbier^{35

36}, A Zurkuhlen¹⁰¹, A Senn¹⁰²

Affiliations

¹ Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
² INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
³ CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
⁴ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
⁵ Regione Emilia Romagna - Agenzia Sanitaria e Sociale, Reference Site of the European Innovation Partnership on Healthy and Active Ageing, Bologna, Italy.
⁶ Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden.
⁷ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
⁸ Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
⁹ ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
¹⁰ GARD Executive Committee, Salvador, Brazil.
¹¹ Kronikgune, International Centre of Excellence in Chronicity Research Barakaldo, Bizkaia Bilbao, Spain.
¹² Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
¹³ Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
¹⁴ Allergy Unit, CUF Porto Instituto and Hospital, Porto, Portugal.
¹⁵ Public Health Agency Northern Ireland, Belfast, UK.
¹⁶ Department of Geriatrics, Medical University of Lodz, Healthy Ageing Research Centre (HARC), Lodz, Poland.
¹⁷ Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
¹⁸ Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
¹⁹ Allergy and Immunology Department, Santa Isabel, Buenos Aires, Argentina.
²⁰ Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico, Mexico.
²¹ Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR), 34000 Montpellier, France.
²² Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
²³ Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
²⁴ Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
²⁵ Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
²⁶ GARD Executive Committee, Manisa, Turkey.
²⁷ Faculty of Medicine, Transylvania University, Brasov, Romania.
²⁸ Kyomed, Montpellier, France.
²⁹ iQ4U Consultants Ltd, London, UK.
³⁰ EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France.
³¹ Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain.
³² IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
³³ CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
³⁴ Universitat Pompeu Fabra (UPF), Barcelona, Spain.
³⁵ Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
³⁶ Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
³⁷ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
³⁸ Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
³⁹ Personalized Medicine Clinic Asthma and Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan Italy.
⁴⁰ Laval's University, Quebec City, Canada.
⁴¹ Hôpital de la Malbaie, Quebec City, Canada.
⁴² CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
⁴³ Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
⁴⁴ Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁴⁵ Allergologia, S Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
⁴⁶ Regional Ministry of Health of Andalusia, Seville, Spain.
⁴⁷ ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
⁴⁸ Department of Health, Social Services and Public Safety, Belfast, Northern Ireland, UK.
⁴⁹ Department of Pediatric, Imperial College London, London, UK.
⁵⁰ Peercode DV, Gerdermalsen, The Netherlands.
⁵¹ Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
⁵² Allergist, Reims, France.
⁵³ Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
⁵⁴ Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
⁵⁵ University Hospital Olomouc - National eHealth Centre, Olomouc, Czech Republic.
⁵⁶ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
⁵⁷ Department of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
⁵⁸ Libra Foundation, Buenos Aires, Argentina.
⁵⁹ Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
⁶⁰ Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
⁶¹ UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Sorbonne Universités, 75013 Paris, France.
⁶² GARD Chairman, Geneva, Switzerland.
⁶³ Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁶⁴ Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Würzburg, Germany.
⁶⁵ Center for Rhinology and Allergology, Wiesbaden, Germany.
⁶⁶ Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, and HARC, Lodz, Poland.
⁶⁷ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet Stockholm, Stockholm, Sweden.
⁶⁸ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
⁶⁹ Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
⁷⁰ Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
⁷¹ Service de Pneumologie, UMR INSERM, UMR1087 and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
⁷² Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
⁷³ Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
⁷⁴ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁷⁵ CIRFF, Federico II University, Naples, Italy.
⁷⁶ Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisbon, Portugal.
⁷⁷ Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
⁷⁸ Clinical and Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Spain.
⁷⁹ Medical Communications Consultant, MedScript Ltd, Dundalk, Co Louth Ireland.
⁸⁰ Argentina Center for Allergy and Immunology, Alassia Children's Hospital, Santa Fe, Santa Fe, Argentina.
⁸¹ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia.
⁸² Department of Immunology, Monash University, Melbourne, VIC Australia.
⁸³ EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
⁸⁴ Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, M13 9WL UK.
⁸⁵ Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou,", University of Athens, Athens, 11527 Greece.
⁸⁶ Allergy and Respiratory Diseases, IRCCS San Martino Hospital, IST-University of Genoa, Genoa, Italy.
⁸⁷ CHU Grenoble, La Tronche, France.
⁸⁸ Observational and Pragmatic Research Institute, Singapore, Singapore.
⁸⁹ Optimum Patient Care, Cambridge, UK.
⁹⁰ Academic Centre of Primary Care, University of Aberdeen, Aberdeen, UK.
⁹¹ Department of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba Canada.
⁹² University Hospital Olomouc, Olomouc, Czech Republic.
⁹³ Global Allergy and Asthma Platform GAAPP, Altgasse 8-10, 1130 Vienna, Austria.
⁹⁴ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
⁹⁵ Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
⁹⁶ Department of ENT, Medical University of Graz, Graz, Austria.
⁹⁷ Pneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
⁹⁸ Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
⁹⁹ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
¹⁰⁰ Queen's University Belfast, Belfast, Northern Ireland, UK.
¹⁰¹ Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
¹⁰² EC-CNECT-H2, European Commission, Brussels, Belgium.

Abstract

A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.

Keywords: ARIA; Asthma; CHRODIS; Good Practices; MASK; Rhinitis; Sunfrail.

Publication types

Review

Grants and funding

G1000758/MRC_/Medical Research Council/United Kingdom